Mutual of America Capital Management’s Harvard Bioscience HBIO Stock Holding History

Mutual of America Capital Management’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-24,994	Closed	-$680K	–	1220
2016 Q3	$680K	Sell	24,994 -3,987	-14%	-$111K	0.01%	1082
2016 Q2	$829K	Sell	28,981 -10,284	-26%	-$327K	0.02%	1050
2016 Q1	$1.19M	Sell	39,265 -30	-0.1%	-$851	0.03%	936
2015 Q4	$1.36M	Sell	39,295 -11,262	-22%	-$385K	0.03%	845
2015 Q3	$1.91M	Sell	50,557 -165	-0.3%	-$7.68K	0.05%	676
2015 Q2	$2.89M	Buy	50,722 +1,271	+3%	+$72.3K	0.06%	490
2015 Q1	$2.88M	Buy	49,451 +2,112	+4%	+$113K	0.06%	514
2014 Q4	$2.68M	Buy	47,339 +1,958	+4%	+$93.3K	0.06%	533
2014 Q3	$1.86M	Buy	45,381 +2,567	+6%	+$118K	0.04%	710
2014 Q2	$1.95M	Hold	42,814	–	–	0.05%	703
2014 Q1	$2.03M	Hold	42,814	–	–	0.05%	665
2013 Q4	$2.01M	Sell	42,814 -9,882	-19%	-$432K	0.05%	659
2013 Q3	$2.1M	Buy	52,696 +10,988	+26%	+$432K	0.06%	586
2013 Q2	$1.5M	Buy	+41,708	New	+$1.6M	0.04%	712

Other funds holding HBIO

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

GPC

Glacier Peak Capital Bellevue, Washington $96.2M AUM 0.45% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mutual of America Capital Management's HBIO Position: Q4 2016 in Review

Mutual of America Capital Management sold out of Harvard Bioscience (HBIO) in Q4 2016, closing a stake of 24,994 shares — an estimated $680K sold.

Mutual of America Capital Management first reported a position in HBIO in Q2 2013 and held it in 14 quarters. The position peaked at $2.89M in Q2 2015. 68 funds tracked by Wall St. Rank hold HBIO as of Q4 2016.

Mutual of America Capital Management reported no remaining Harvard Bioscience position as of Q4 2016 after selling out during the quarter.
Mutual of America Capital Management sold 24,994 Harvard Bioscience shares in Q4 2016, an estimated $680K.
Mutual of America Capital Management first reported a position in Harvard Bioscience in Q2 2013 and held it in 14 quarters.
Mutual of America Capital Management's Harvard Bioscience position peaked at $2.89M in Q2 2015.
68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2016.

Based on Mutual of America Capital Management's 13F filing for Q4 2016, filed 31 Jan 2017.